ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1164

Canadians’ Views about Using Big Data in Health Research from a National Online Survey: A Partnership of Patient-Consumers and Researchers

Natalie McCormick1, Clayon Hamilton1,2, Cheryl L. Koehn3, Kelly English4, Allan Stordy5 and Linda Li1,6, 1Arthritis Research Canada, Richmond, BC, Canada, 2Physical Therapy, The University of British Columbia, Vancouver, BC, Canada, 3Arthritis Consumer Experts, Vancouver, BC, Canada, 4Arthritis Patient Advisory Board, Arthritis Research Canada, Richmond, BC, Canada, 5Canadian Skin Patient Alliance, Calgary, AB, Canada, 6Department of Physical Therapy, The University of British Columbia, Vancouver, BC, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: administrative databases, Education, Electronic Health Record, patient engagement and privacy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Epidemiology and Public Health Poster II – ARHP

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:                 

Findings from health research using “big data” (large sets of routinely-collected healthcare data) have benefitted individual arthritis patients and society as-a-whole.  However, growing public concerns about personal information being accessed for unintended purposes could erode trust in this research and its potential benefits.

We conducted this study to elucidate the public’s views on the role of big data in health research.

Methods:

This was a partnership between researchers at Arthritis Research Canada and consumer-patient leaders from three joint and skin disease patient organizations.  We developed an online survey assessing: 1) Perceptions about the role of big data in health research and access and privacy controls, 2) Willingness to participate in projects using big data, 3) Major concerns, and 4) Interest in learning more.  Respondents were recruited via the websites, e-mail lists, and social media channels of Canadian health research groups, including the three patient organisations.

Survey: Our three-part, ~20-min. survey was open from Jan-Aug 2017.  Part 1 asked about respondents’ familiarity and initial perceptions about using big data in health research.  In Part 2 they were provided with some background information, then asked their views on specific topics (i.e. benefits of using big data, data access and privacy).  In Part 3 respondents were queried further about their perceptions of big data and ongoing educational needs. 

Analysis:

For each question, we calculated the percentage of respondents selecting each response option. 

Results:

151 individuals completed the survey (117=77% female; 47% aged 50-69 years, 28% aged 30-49 years).  101 (67%) had a chronic disease. 

At the start of the survey (Part 1), 79% of respondents felt positively about the use of big data for health research and 95% knew the term “electronic health/medical record”, but only 58% knew the terms “administrative data/health database”. 

In Part 2, respondents felt the ability to study large numbers of people (selected by 73%) and long-term effects and rare events (76%) were the top benefits of using big data; long-term treatment effects and disease complications were the most important research topics (see Table).

59% felt the use of big data should be approved by university research ethics boards, and 67% wanted to learn more about how data stewards grant access to data.  De-identifying personal information was the most important privacy measure (selected by 89%).

At the end of the survey (after viewing background information about big data), 93% felt positively about big data (vs. 79% at the start), but only 58% were confident about privacy and security measures in place. 

Conclusion:

While ethics board approvals and de-identification of healthcare data were highly regarded, more public education, especially about data access and privacy controls, may enhance public trust about using big data in health research.

Table: Percentage of Respondents Selecting Each Feature and Data Access/Privacy Measure Described in Part 2 of the Survey

(Most- to Least-Frequently Selected)

Advantages of Using Big Data for Health Research

Most Important (select up to 3)

1. Long-Term Effects and Rare Events

2. Large Numbers

3. Study Potentially-Harmful Treatments

4. General Population Comparisons

5. More Inclusive

75.5%

72.8%

50.3%

46.4%

43.0%

Want Additional Information About

(select up to 3)

1. Study Potentially-Harmful Treatments

2. Long-Term Effects and Rare Events

3. Large Numbers

4. General Population Comparisons

5. More Inclusive

64.2%

63.6%

44.4%

41.7%

35.1%

Health Research Questions to Study Using Big Data

Most Important (select up to 3)

1. Treatment Benefits

2. Treatment Harms

3. Disease Complications

4. Changes in Policy or Practice

5. Quality of Care

6. Cost-Effectiveness

7. Risk Factors for Disease

8. Disease Incidence and Prevalence

55.6%

55.0%

52.3%

43.7%

30.5%

27.8%

23.2%

9.9%

Data Access Controls

Most Important

(select up to 2)

1. Must Apply for Data Access

2. Approval from Research Ethics Board

3. Approval from Data Stewards

4. Access Data for Limited Time

62.3%

58.9%

51.0%

20.5%

Want Additional Information About

(select up to 2)

1. Approval from Data Stewards

2. Approval from Research Ethics Board

3. Access Data for Limited Time

4. Must Apply for Data Access

66.9%

46.4%

29.8%

25.2%

Privacy and Security Controls

Most Important

(select up to 3)

1. Data are

De-Identified

2. Privacy Training and Confidentiality Agreement

3. Review of Research Outputs

4. Funding Agencies Cannot Access Data

5. No Access Outside Canada

89.4%

57.6%

43.7%

35.8%

35.1%

Expressed as the percentage selecting each response option; as multiple responses could be selected, the sum of percentage-frequencies exceeds 100%


Disclosure: N. McCormick, None; C. Hamilton, None; C. L. Koehn, None; K. English, None; A. Stordy, None; L. Li, None.

To cite this abstract in AMA style:

McCormick N, Hamilton C, Koehn CL, English K, Stordy A, Li L. Canadians’ Views about Using Big Data in Health Research from a National Online Survey: A Partnership of Patient-Consumers and Researchers [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/canadians-views-about-using-big-data-in-health-research-from-a-national-online-survey-a-partnership-of-patient-consumers-and-researchers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/canadians-views-about-using-big-data-in-health-research-from-a-national-online-survey-a-partnership-of-patient-consumers-and-researchers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology